[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China Research and Intelligence Co., Ltd.: Market Research Reports

China Research and Intelligence (CRI) has emerged to provide high-level research and advisory services to all those with keen interest in different Chinese markets and industries. The firm, founded in 2007, is headquartered in Shanghai, China. Their team’s principle goal is to present the most helpful and reliable insights and information, sincerely serving a broad choice of multinational and local customers with their business practice and ethics.

CRI’s reports are packed with precise analysis of key market indicators, strategic recommendations from industry experts, market estimated figures, projections, reviews of competitive strategies, consumers investigation, reviews of business models, market share analyses, key forces driving of restraining market growth.

CRI’s scope of offerings encircles numerous market research reports, industry analytical reviews, company business reports, industry-specific research databases. Further, the company also offers outsource and custom-tailored services for research organisations, and multiple report readers.

Publications found: 946
Sort by:
Investigation Report on China's Aflibercept Market 2021-2025 US$ 2,600.00

Aflibercept is an anti-VEGF drug, mainly used to treat neovascular age-related macular degeneration (wAMD), and other retinopathy caused by visual impairment. Aflibercept was jointly developed by Rege...

April 2021 40 pages
Investigation Report on China's Human Serum Albumin Market 2021-2025 US$ 2,600.00

Human Serum Albumin (HSA) is made of plasma proteins from human blood, which is mainly used to replace blood volume loss resulting from trauma such as a severe burn or an injury that causes blood loss...

April 2021 50 pages
Investigation Report on China's Ibrutinib Market 2021-2025 US$ 2,600.00

Ibrutinib is a BTK inhibitor, mainly used to treat B-cell carcinomas, such as mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenstrom's macroglobulinemia. Ibrutinib was first developed by...

April 2021 40 pages
Investigation Report on China's Iodixanol Market 2021-2025 US$ 2,600.00

Iodixanol is a third-generation contrast agent that has good solubility and is isotonic to plasma. It is used for cardiovascular angiography, cerebrovascular angiography, abdominal angiography, and so...

April 2021 50 pages
Investigation Report on China's Lenalidomide Market 2021-2025 US$ 2,600.00

Lenalidomide is an oral immunomodulatory drug that is mainly used to treat blood cancers such as multiple myeloma, myelodysplastic syndrome, and lymphoma. Lenalidomide was first developed by Celgene....

April 2021 50 pages
Investigation Report on China's Meropenem Market 2021-2025 US$ 2,600.00

Meropenem is an antibiotic that is used to treat a variety of bacterial infections, including meningitis, pneumonia and so on. Meropenem is jointly developed by Sumitomo Dainippon Pharma and Imperial...

April 2021 50 pages
Investigation Report on China's Nivolumab Market 2021-2025 US$ 2,600.00

Nivolumab is a human IgG4 monoclonal antibody that blocks PD-1, mainly used to treat non-small cell lung cancer, gastric or gastroesophageal junction adenocarcinoma, advanced renal cell carcinoma, and...

April 2021 50 pages
Investigation Report on China's Oseltamivir Market 2021-2025 US$ 2,600.00

Oseltamivir is an antiviral drug used to treat or prevent influenza virus type A and B. Oseltamivir was invented by Gilead Sciences, and Roche purchased the rights to develop and market Oseltamivir un...

April 2021 50 pages
Investigation Report on China's Osimertinib Market 2021-2025 US$ 2,600.00

Osimertinib is a small molecule targeted anti-tumor drug used to treat non-small cell lung cancer (NSCLC). The original drug, TAGRISSO was developed by AstraZeneca. Osimertinib was launched in China i...

April 2021 50 pages
Investigation Report on China's Rituximab Market 2021-2025 US$ 2,600.00

Rituximab is a monoclonal antibody to target cells that have the CD20 marker on their surface. It is mainly used to treat diseases caused by excessive B lymphocytes, including lymphoma, chronic lympho...

April 2021 50 pages
Investigation Report on China's Tacrolimus Market 2021-2025 US$ 2,600.00

Tacrolimus is a macrolide antibiotic and is also a new immunosuppressant. It is available in a variety of dosage forms. The ointment is used for moderate to severe atopic dermatitis where traditional...

April 2021 50 pages
Investigation Report on China's Trastuzumab Market 2021-2025 US$ 2,600.00

Trastuzumab is a monoclonal antibody used to treat breast cancer and stomach cancer, and is especially used for the treatment of certain HER-2 positive cancers. The original drug, HERCEPTIN was develo...

April 2021 50 pages
Investigation Report on Chinese Clopidogrel Market 2021-2025 US$ 2,600.00

Clopidogrel is a medication that inhibits platelet aggregation and is mainly used to prevent atherosclerotic thrombosis. The original drug, Plavix, is developed by Sanofi. It enters the Chinese market...

April 2021 50 pages
Investigation Report on Chinese Atorvastatin Market 2021-2025 US$ 2,600.00

... demand for Atorvastatin. TOPICS COVERED: Development environment of Atorvastatin in China Sales of Atorvastatin in China Prices of Atorvastatin in China Major Atorvastatin manufacturers in China Market share of Atorvastatin by dosage form in China Prospect of Chinese Atorvastatin Market, 2018-2022 ...

April 2021 50 pages
Investigation Report on China's Ambroxol Market, 2021-2025 US$ 2,600.00

... Pharmaceutical (Qianshan) Co., Ltd. Ambroxol is sold in China in the dosage forms of ... China Size of China's Ambroxol market Competitive landscape of China's Ambroxol market Prices of Ambroxol in China Analysis on factors affecting the development of China's Ambroxol market Prospect of China's Ambroxol ...

April 2021 50 pages
Investigation Report on China's Recombinant Lispro Insulin Market, 2021-2025 US$ 2,600.00

... market in China Market size of Recombinant Lispro Insulin in China Major Recombinant Lispro Insulin manufacturers in China Prices of Recombinant Lispro Insulin in China Major factors affecting the development of China's Recombinant Lispro Insulin market Prospect of China's Recombinant Lispro Insulin market

April 2021 50 pages
Investigation Report on China's Hydroxychloroquine Market, 2021-2025 US$ 2,600.00

Hydroxychloroquine is commonly used to prevent and treat malaria. The pharmacokinetics of hydroxychloroquine is similar to that of chloroquine. It can be rapidly absorbed in the gastrointestinal tract...

April 2021 50 pages
Investigation Report on Chinese Adalimumab Market, 2021-2025 US$ 2,600.00

In 2010, Adalimumab entered the Chinese market. Its original drug is produced by AbbVie Inc., under the brand name HUMIRA. The sales of HUMIRA is ranking at Top one among all pharmaceutical products s...

April 2021 40 pages
Investigation Report on Chinese Apixaban Market 2021-2025 US$ 2,600.00

Anticoagulation therapy plays an important role in the prevention and treatment of thromboembolic diseases. The two most famous drugs are Rivaroxaban and Apixaban, mainly used to prevent and treat ven...

April 2021 50 pages
Investigation Report on Chinese Bevacizumab Market 2021-2025 US$ 2,600.00

Bevacizumab is the world's first humanized monoclonal antibody for anti-tumor angiogenesis, which can be used to treat colon cancer and other solid tumors. AVASTIN, the original research drug (develop...

April 2021 50 pages
Investigation Report on Chinese Budesonide Market 2021-2025 US$ 2,600.00

Budesonide is an adrenal cortex hormone medicine. It is available in different forms, such as inhalant, nasal spray, and so on. The inhalation form is used to treat asthma and chronic obstructive pulm...

April 2021 50 pages
Investigation Report on Chinese Cefoperazone Sodium and Sulbactam Sodium Market 2021-2025 US$ 2,600.00

Cefoperazone Sodium and Sulbactam Sodium is an injectable antibiotic. The original drug is SULPERAZON, developed by Pfizer. In addition to Pfizer, the other main manufacturers in the Chinese market ar...

April 2021 50 pages
Investigation Report on Chinese Dezocine Market, 2021-2025 US$ 2,600.00

Dezocine is an opioid analgesic that relieves pain. Dezocine was launched in China in 2009 and has been widely used in general anesthesia induction, postoperative analgesia, and preemptive analgesia....

April 2021 50 pages
Investigation Report on Chinese Pembrolizumab Market, 2021-2025 US$ 2,600.00

Pembrolizumab is a humanized PD-1 monoclonal antibody used for cancer immunotherapy. It currently has the most approved indications, as well as it is used in more tumors’ treatments than other drugs a...

April 2021 50 pages
Investigation Report on Chinese Sevoflurane Market, 2021-2025 US$ 2,600.00

Sevoflurane is an inhalation general anesthetic and also the main inhalation anesthetic at this stage. Inhaled Sevoflurane was originally developed by Abbott and entered the Chinese market in 1996. In...

April 2021 50 pages
Research Report on China Tire Export 2020-2024 US$ 2,000.00

... product and market structure of exported tires have made anti-dumping a serious issue facing tire exporters in China. Currently, China’s large-scale tire export ... demand, as auto production and sales start to fall, the expectation of growth in tire market has decreased too. Besides, tire industry is troubled ...

July 2020 20 pages
Research Report on China Disposal Face Mask Industry 2020-2024 US$ 2,200.00

Description Globally, as of 13 July 2020, there have been 13,235,751 confirmed cases of COVID-19, including 575,525 deaths. Since COVID-19 is spreading over 100 countries, there are more than 13 milli...

July 2020 30 pages
Research Report on China Mobile Phone Export 2020-2024 US$ 2,000.00

Description According to CRI, from 2017 to 2019, the total volume of China's mobile phone exports declined from 1,213.22 million to 994.09 million. Although the total export volume showed a trend of d...

July 2020 20 pages
Research Report on China Wig Export 2020-2024 US$ 2,000.00

Description Materials of wigs include human hair, chemical fiber, high-temperature protein silk and animal hair, etc. Among them, human hair wigs are the best, and most expensive. The exported wig pro...

July 2020 20 pages
Research Report on Imported Barley in China 2020-2024 US$ 2,200.00

Description According to CRI, with the development of feed and beer industries, China has a large consumption scale of barley, while the domestic supply was only around 1 million tons per year, which...

July 2020 30 pages
Research report on imported grape wine in China 2020-2024 US$ 2,200.00

Description According to CRI, China is the world's fifth largest wine consumer. Grape wine is the second largest alcoholic beverage in the world after beer and has a long history in China, but it is r...

July 2020 30 pages
Research report on imported salmon in China 2020-2024 US$ 2,200.00

Description Salmon is the common name for several species of ray-finned fish in the family Salmonidae. With high nutrition, salmon becomes more and more common in Chinese people’s life. 75% of salmon...

July 2020 30 pages
Research report on imported soybeans in China 2020-2024 US$ 2,200.00

Description Soybeans are important raw materials of common edible oil and feed material of breeding industry in China. China has huge demand on Soybeans while the domestic supply could not meet the co...

July 2020 30 pages
Investigation Report on Chinese Pregabalin Market, 2020-2024 US$ 2,200.00

... prospect in China. Topics Covered: Development environment of Chinese Pregabalin market Governmental approval of Pregabalin in China Prices of Pregabalin in China Major Pregabalin manufacturers in China Factors influencing the development of Chinese Pregabalin market Prospects of Chinese Pregabalin market

January 2020 30 pages
Report on Imported Recycled Paper in China 2020-2024 US$ 2,200.00

With the development of China’s economy, the consumption of paper and paperboards has continued to increase, which has promoted the production. China has become the world's largest producer of paper a...

January 2020 30 pages
Research Report of Beef Import in China 2020-2024 US$ 2,200.00

With the development of China’s economy and the improvement of living standards, the demand for beef in China is rising. The upward cattle breeding cost makes it difficult to sharply increase the beef...

January 2020 40 pages
Research Report of Import of Dairy Products Industry in China 2020-2024 US$ 2,400.00

According to CRI, with the development of China’s economy and the arise in Chinese people’s living standards, the per capita consumption of dairy products in China keeps rising. Despite the increasing...

January 2020 40 pages
Research Report of Import of Pork in China 2020-2024 US$ 2,200.00

According to CRI, with the development of China’s economy and the improvement of living standards, the pork consumption in China is rising. China is the largest pork producer in the world. But pig bre...

January 2020 30 pages
Research Report of Organ Transplantation in China 2020-2024 US$ 2,200.00

According to CRI’s market research, transplantation has become an important way to save the lives of patients with critical diseases such as liver failure and kidney failure. Human organ transplantati...

January 2020 30 pages
Research Report on China's Ship Accessory Equipment Industry 2020-2024 US$ 2,400.00

According to CRI, the ship equipment industry is a major part of the comprehensive strength of the shipping industry. The ship equipment manufacturing industry mainly concentrates in coastal areas inc...

January 2020 40 pages
Vietnam Cement Industry Report 2020-2024 US$ 2,200.00

Thanks to strong domestic supply and robust export activities, Vietnam cement and clinker sales volume reached record high in 2018, increasing rate 58.71% YOY, which made Vietnam ranked first of cemen...

January 2020 30 pages
Vietnam Steel Industry Report 2020-2024 US$ 2,400.00

The growth rate of Vietnam's GDP in 2018 was about 7.08%, a relatively high level in Southeast Asia. Vietnam's economy has been increasing rapidly for many years, but wages of the manufacturing are st...

January 2020 40 pages
Investigation Report on China's Finasteride Market, 2019-2023 US$ 2,200.00

... prostatic hyperplasia in China Status of China's Finasteride market Competition on China's Finasteride market Major Finasteride manufacturers in China Prices of Finasteride in China Major factors influencing the development of China's Finasteride market Prospect of China's Finasteride market from ...

September 2019 30 pages
Investigation Report on China's Pegaspargase Market, 2019-2023 US$ 2,200.00

... of leukemia in China Status of China's Pegaspargase market Retail prices of Pegaspargase in China Major factors influencing the development of China's Pegaspargase market Prospect of China's Pegaspargase market from 2019 to 2023 Progress of generic Pegaspargase in China

September 2019 30 pages
Investigation Report on China's Prothrombin Complex Concentrate (PCC) Market, 2019-2023 US$ 2,200.00

... hemophiliacs in China at the end of 2018. And most of them failed to receive timely treatment because they had no ability to pay. Prothrombin complex concentrate (PCC ... of PCC and there are few manufacturers of PCC in China, China’s PCC market is highly concentrated with CR5 of more than 90%. In 2017, Hualan ...

September 2019 30 pages
Investigation Report on China's Recombinant Human Thrombopoietin Market, 2019-2023 US$ 2,200.00

... with thrombopenia increases in China, the demand for Recombinant Human Thrombopoietin will also increase. Considering the high growth rate of the Recombinant Human Thrombopoietin market, Recombinant Human Thrombopoietin products by other ...

September 2019 30 pages
Investigation Report on China's Basiliximab Market, 2019-2023 US$ 2,200.00

... transplantation remain major clinical problems. In China, Basiliximab is used to prevent early acute rejection ... China Status of China's Basiliximab market Retail prices of Basiliximab in China Major factors influencing development of China's Basiliximab market from 2019 to 2023 Prospect of China's Basiliximab ...

August 2019 30 pages
Investigation Report on China's Diclofenac Market, 2019-2023 US$ 2,200.00

... : Incidence of rheumatoid arthritis in China Supply of and demand for Diclofenac in China Retail prices of Diclofenac in China Major factors influencing China's Diclofenac market Prospect of China's Diclofenac market from 2019 to 2023

August 2019 30 pages
Investigation Report on China's Polyene Phosphatidylcholine Market, 2019-2023 US$ 2,200.00

... viral hepatitis in China Development of Polyene Phosphatidylcholine in China Major Polyene Phosphatidylcholine manufacturers in China and competition on China's Polyene Phosphatidylcholine market Retail prices of Polyene Phosphatidylcholine in China Prospect of China's Polyene Phosphatidylcholine market from ...

August 2019 30 pages
Investigation Report on China's Recombinant Follitropin Beta Market, 2019-2023 US$ 2,200.00

... TOPICS COVERED: Incidence of infertility in China Status of China's Recombinant Follitropin Beta market Prices of Recombinant Follitropin Beta in China Major factors influencing development of China's Recombinant Follitropin Beta market Prospect of China's Recombinant Follitropin Beta market from 2019 to 2023 ...

August 2019 30 pages

Filters

Search

Categories

1
1
1
3
3
1
2
1
1
2
1
1
1
3
1
1
1
1
1
7
2
1
1
1
2
1
1
5
2
1
6
1
1
1
1
4
4
1
1
4
2
3
3
2
1
1
8
3
2
3
2
5
2
1
1
1
1
14
10
2
1
1
1
1
1
1
1
1
46
6
3
1
1
1
1
3
3
1
1
1
4
4
2
1
1
5
9
6
2
4
1
12
9
7
7
7
6
6
4
4
3
2
2
2
2
1
1
217
16
10
10
9
7
6
6
3
3
2
2
1
1
7
4
2
1
9
4
3
3
1
7
19
3
2
7
3
2
2
1
1
67
62
44
14
11
9
6
6
5
3
3
3
2
2
2
1

Publishers

946

Regions

5
1
15
3
1
1
1
919

Price

Date

Pages

Offers